vimarsana.com

Latest Breaking News On - Maintenance therapy - Page 4 : vimarsana.com

Treatment Sequencing and Combination Therapies for MM

Carol Ann Huff, MD discusses how the approval of additional bispecific antibodies for multiple myeloma might change the treatment selection process, highlighting considerations for sequencing of agents and combination therapy.

ASH 2023: Multiple Myeloma s Shifting Landscape: Trials and Clinical Perspectives

Health care professionals review the 2023 American Society of Hematology Annual Meeting and Exposition (ASH 2023) multiple myeloma revelations, spotlighting transformative trials, groundbreaking translational research, and clinical perspectives that illuminate the evolving treatment landscape.

Multiple Myeloma Frontline Horizon: Quads, Bispecifics, and Breakthroughs

Experts review groundbreaking insights from review the 2023 American Society of Hematology Annual Meeting and Exposition (ASH 2023) and discuss the paradigm shift in myeloma frontline treatments, exploring quads, bispecifics, and the dynamic evolution of therapeutic approaches.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.